The AJMC® Chronic Kidney Disease compendium is a comprehensive resource for clinical news and expert insights on the condition and treatment of loss of kidney function.
October 6th 2023
The data show the average age of dialysis in the least vulnerable neighborhoods was 68.2 years old, but 59.4 years—almost a decade earlier—in the most vulnerable.
Caring for Individuals With Kidney Disease During the Pandemic
January 20th 2021Nephrologist Mary Dittrich, MD, the chief medical officer and executive vice president of U.S. Renal Care as well as cofounder and partner of Boise Kidney & Hypertension Institute, discusses how to keep patients safe while providing high-quality kidney care during the coronavirus disease 2019 pandemic.
Read More
Family History, Genetics May Help to Predict, Detect Early-Stage CKD
January 16th 2021A population-based study from the Netherlands showed that individuals with had at least 1 direct relative affected with chronic kidney disease (CKD), suggesting that biomarkers for CKD can aid in detecting the early stages of the disease.
Read More
Dr Guofen Yan Considers Strategies for Improving CKD Outcomes in Minority Populations
December 31st 2020Slowing progression of chronic kidney disease can help mitigate adverse outcomes in minority populations, said Guofen Yan, PhD, associate professor of biostatistics in the Department of Public Health Sciences at the University of Virginia School of Medicine.
Watch
Dr Kunihiro Matsushita Lays Out the Benefits of the CKD Patch Approach
December 31st 2020This approach allows clinicians to keep using existing prediction models and incorporate chronic kidney disease (CKD) data seamlessly to calibrate patients' risks, said Kunihiro Matsushita, MD, an associate professor in the Department of Epidemiology and Division of Cardiology at Johns Hopkins University.
Watch
Top 5 Most-Read Chronic Kidney Disease Articles of 2020
December 28th 2020Two story lines predominated renal news in 2020: coronavirus disease 2019's effect on the kidneys and the overwhelming benefits of sodium-glucose cotransporter 2 inhibitors for those with chronic kidney disease and type 2 diabetes.
Read More
Virtual Platform Allows Transplant Evaluations, Wait-Listing to Continue Despite Pandemic
December 26th 2020A study evaluating whether a virtual platform can improve access to evaluations for kidney transplants found that surgical teams could continue to keep up with evaluations adding patients to wait lists during the pandemic.
Read More
Researchers Discuss Closing Racial Gaps in ESKD Incidence Rates
December 19th 2020Bringing together genetic work with social determinants of health can improve understanding of factors associated with ESKD disparities, said Adriana Hung, MD, MPH, associate professor of medicine at Vanderbilt University, and Bryce Rowan, a statistical genetic analyst.
Watch
Dr George Bakris on Discontinuation Rates, CV Outcomes of FIDELIO-DKD
December 12th 2020A variety of factors contributed to discontinuation rates in FIDELIO-DKD, said George Bakris, MD, professor of medicine and director of the American Heart Association Comprehensive Hypertension Center at the University of Chicago Medicine.
Watch
Study Examines Clinical Implications of Removing Race From eGFR in CKD
December 4th 2020As higher estimated glomerular filtration rate (eGFR) equations indicate better kidney function, there has been increasing recognition that this may lead to inequitable and delayed care in treating chronic kidney disease (CKD) in Black adults.
Read More
Dr Jill Krissberg on Addressing Racial Disparities in Glomerular Disease
December 3rd 2020Making sure patients have a strong medical home and close follow-up is one way to reduce glomerular disease disparities among children, said Jill Krissberg, MD, a pediatric nephrology fellow at Stanford University School of Medicine.
Watch
Contributor: The Wrong Way to Design a Medicare Mandatory Demonstration
November 27th 2020Jackson Williams is vice president, public policy at Dialysis Patient Citizens. Previously he worked at the Centers for Medicare and Medicaid Services (CMS); was a health services researcher in the AARP Public Policy Institute; and a lobbyist on health policy issues for 3 nonprofit associations. His more than 2 decades of experience monitoring, studying, and overseeing federal demonstration projects include time as a project officer at CMMI and serving as the consumer representative on a Medicare pilot site’s governing body.
Read More
Dr George Bakris Discusses Next Steps for Finerenone
November 27th 2020If results from FIGARO-DKD are as positive as those of FIDELIO-DKD, the field will work aggressively to get the message out, said George Bakris, MD, professor of medicine and director of the American Heart Association Comprehensive Hypertension Center at the University of Chicago Medicine.
Watch
Dr George Bakris Speaks About Increasing Minority Representation in CKD Trials
November 21st 2020In the FIDELIO-DKD trial researchers purposely recruited centers that had very large African American databases, said George Bakris, MD, professor of medicine and director of the American Heart Association Comprehensive Hypertension Center at the University of Chicago Medicine.
Watch
Dr Rajiv Agarwal on the Future of Finerenone
November 13th 2020The FIDELIO-DKD program is perhaps just the beginning of seeing how finerenone can be used, said Rajiv Agarwal, MD, MS, FASN, a professor of medicine at Indiana University School of Medicine and a staff physician at the Veterans Affairs Medical Center in Indianapolis, Indiana.
Watch
Primary Care Referrals to Nephrology in Patients With Advanced Kidney Disease
Primary care physicians did not refer the majority of patients with severe nephropathy to specialists; nonreferred patients had fewer comorbidities and might be better kidney transplant candidates.
Read More
Dr Joshua Rein Discusses the Next Steps of Cannabis Treatment for Kidney Disease
October 31st 2020The federal illegality and Schedule I listing of cannabis significantly impair our ability to conduct any kind of prospective clinical research, said Joshua L Rein, DO, FASN, a nephrologist at Mt. Sinai Hospital in New York City.
Watch
Research Highlights Impact of SDOH on Veterans With CKD
October 30th 2020A pair of abstracts presented at Kidney Week 2020 underscore the relationship between social determinants of health (SDOH) and chronic kidney disease (CKD) in military populations and the challenges of tracking these factors.
Read More